AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

 Permalink  Uncategorized  Comments Off on
May 282013
 

Rituximab (trade names Rituxan and MabThera) is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cells. Rituximab destroys B cells, and is therefore used to treat diseases which are characterized by excessive numbers of B cells, overactive B cells, or dysfunctional B cells. This includes many lymphomas, leukemias, transplant rejection, and autoimmune disorders.

Rituxan

Tiny Biotech Developing Drugs Akin To Biogen’s Rituxan Seen As Potential
Forbes
One small biopharmaceutical that believes it has a proven technology for another blockbuster is TG Therapeutics (TGTX), which is focused on developing drugs for the treatment of cancer and other underserved therapeutic needs, including hematologic …read all

http://www.forbes.com/sites/genemarcial/2013/05/27/tiny-biotech-developing-drugs-akin-to-biogens-rituxan-seen-as-potential-buyout-bet/

Share

CFDA Approves Clinical Trials for Novel China AIDS Treatment, Azi Fu (Azvudine)

 AIDS, Uncategorized  Comments Off on CFDA Approves Clinical Trials for Novel China AIDS Treatment, Azi Fu (Azvudine)
May 282013
 

Links

http://newdrugapprovals.wordpress.com/2013/05/28/cfda-approves-clinical-trials-for-novel-china-aids-treatment-azi-fu-azvudine/

Share

China’s Curative Medical to Seek CFDA Approval for ALung’s Respiratory Device

 china, Uncategorized  Comments Off on China’s Curative Medical to Seek CFDA Approval for ALung’s Respiratory Device
May 272013
 

 

Links

read all at

http://newdrugapprovals.wordpress.com/2013/05/27/chinas-curative-medical-to-seek-cfda-approval-for-alungs-respiratory-device/

Share

AbbVie and Eisai Announce HUMIRA® Pre-filled Syringe Has Received Approval for the Treatment of Intestinal Behçet’s Disease in Japan

 Uncategorized  Comments Off on AbbVie and Eisai Announce HUMIRA® Pre-filled Syringe Has Received Approval for the Treatment of Intestinal Behçet’s Disease in Japan
May 272013
 

Links

 

read all at

http://newdrugapprovals.wordpress.com/2013/05/27/abbvie-and-eisai-announce-humira-pre-filled-syringe-has-received-approval-for-the-treatment-of-intestinal-behcets-disease-in-japan/

Share

RESVERATROL AND ITS BENEFITS

 Uncategorized  Comments Off on RESVERATROL AND ITS BENEFITS
May 272013
 

SEE MY PRESENTATION

Links

 

http://newdrugapprovals.wordpress.com/2013/05/27/resveratrol-and-its-benefits-my-presentation-on-slideshare/

OR

http://www.slideshare.net/anthonycrasto64/anthony-crasto-resveratrol-synthesis-and-benefits

Share

Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease Medicine

 Phase 3 drug, Uncategorized  Comments Off on Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease Medicine
May 262013
 

PREDADENANT

 

Links

http://newdrugapprovals.wordpress.com/2013/05/26/merck-provides-update-on-phase-iii-clinical-program-for-preladenant-the-companys-investigational-parkinsons-disease-medicine/

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: